These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30794355)

  • 1. [Threats to the Effectiveness of Malaria Treatment].
    Pays JF
    Bull Soc Pathol Exot; 2018; 111(4):195-196. PubMed ID: 30794355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Threats to the Effectiveness of Malaria Treatment].
    Pays JF
    Bull Soc Pathol Exot; 2018; 111(4):199-200. PubMed ID: 30794356
    [No Abstract]   [Full Text] [Related]  

  • 3. Threats to the Effectiveness of Malaria Treatment.
    Pays JF
    Bull Soc Pathol Exot; 2018; 111(4):197-198. PubMed ID: 30794359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
    Noubiap JJ
    J Infect Public Health; 2014; 7(5):407-12. PubMed ID: 24894306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of artesunate for the treatment of severe malaria.
    Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ
    Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imported malaria: safer and more efficacious drugs?].
    Genton B; D'Acremont V
    Rev Med Suisse; 2013 May; 9(385):979-84. PubMed ID: 23750390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of a dedicated support group in retaining malaria-free status of Sri Lanka.
    Datta R; Mendis K; Wikremasinghe R; Premaratne R; Fernando D; Parry J; Rolfe B
    J Vector Borne Dis; 2019; 56(1):66-69. PubMed ID: 31070169
    [No Abstract]   [Full Text] [Related]  

  • 8. Artesunate versus quinine for treating severe malaria.
    Jones KL; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005967. PubMed ID: 17943870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for the treatment of malaria in the Kingdom of Saudi Arabia.
    Nzila A; Al-Zahrani I
    Saudi Med J; 2013 Jun; 34(6):569-78. PubMed ID: 23756920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of malaria eradication in the twenty-first century: research linked to operations is the key.
    Breman JG; Brandling-Bennett AD
    Vaccine; 2011 Dec; 29 Suppl 4():D97-103. PubMed ID: 22284402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate versus quinine for treating severe malaria.
    Sinclair D; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2011 Mar; (3):CD005967. PubMed ID: 21412892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malaria therapy; ups and downs, how much longer?].
    Kager PA
    Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1764-6. PubMed ID: 9545723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of malaria: recent trends.
    Mehta SR; Das S
    J Commun Dis; 2006 Mar; 38(2):130-8. PubMed ID: 17370675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate for severe malaria.
    Lancet; 2011 Apr; 377(9776):1466. PubMed ID: 21531257
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.
    Honrado ER; Fungladda W; Kamoiratanaku P; Kitayaporn D; Karbwang J; Thimasarn K; Masngammueng R
    Bull World Health Organ; 1999; 77(3):235-43. PubMed ID: 10212514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fight against malaria: progress and resistance].
    Nau JY
    Rev Med Suisse; 2015 Sep; 11(488):1818-9. PubMed ID: 26619706
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of mass drug administration for malaria and its operational challenges.
    Newby G; Hwang J; Koita K; Chen I; Greenwood B; von Seidlein L; Shanks GD; Slutsker L; Kachur SP; Wegbreit J; Ippolito MM; Poirot E; Gosling R
    Am J Trop Med Hyg; 2015 Jul; 93(1):125-134. PubMed ID: 26013371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.